Kumar Brothers Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-10-2024
- Paid Up Capital ₹ 1.00 M
as on 24-10-2024
- Company Age 19 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.21 Cr
as on 24-10-2024
- Satisfied Charges ₹ 3.00 Cr
as on 24-10-2024
- Revenue 7.45%
(FY 2023)
- Profit -6.14%
(FY 2023)
- Ebitda -1.78%
(FY 2023)
- Net Worth 6.06%
(FY 2023)
- Total Assets -4.64%
(FY 2023)
About Kumar Brothers Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹3.21 Cr. The company has closed loans amounting to ₹3.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Surendra Jain, Bhavesh Surendra, Kumarpal Jain, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230MH2005PTC151712
- Company No.
151712
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Mar 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Kumar Brothers Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Surendra Jain  | Managing Director | 02-Mar-2005 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bhavesh Surendra | Director | 02-Mar-2005 | Current |
| Kumarpal Jain | Director | 03-Dec-2018 | Current |
| Kunal Jain | Director | 03-Dec-2018 | Current |
Financial Performance of Kumar Brothers Pharma.
Kumar Brothers Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.45% increase. The company also saw a slight decrease in profitability, with a 6.14% decrease in profit. The company's net worth moved up by a moderate rise of 6.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kumar Brothers Pharma?
In 2023, Kumar Brothers Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kolor Bio - Genetics Private LimitedActive 15 years 8 monthsKumarpal Jain and Kunal Jain are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 09 Apr 2015 | ₹1.50 Cr | Open |
Hdfc Bank Limited Creation Date: 05 Sep 2006 | ₹1.25 Cr | Open |
The United Western Bank Ltd. Creation Date: 25 Oct 2005 | ₹3.60 M | Open |
How Many Employees Work at Kumar Brothers Pharma?
Kumar Brothers Pharma has a workforce of 25 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kumar Brothers Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kumar Brothers Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
